Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial
- PMID: 32453692
- PMCID: PMC7250693
- DOI: 10.2450/2020.0109-20
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial
Conflict of interest statement
The Authors declare no conflicts of interest.
Comment in
-
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".Blood Transfus. 2020 May;18(3):239-240. doi: 10.2450/2020.0116-20. Blood Transfus. 2020. PMID: 32453693 Free PMC article. No abstract available.
Comment on
-
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8. Blood Transfus. 2020. PMID: 32281926 Free PMC article. No abstract available.